Skip to main content
Dhanuka Agritech Ltd. logo

Dhanuka Agritech Ltd. — Investor Relations & Filings

Ticker · DHANUKA ISIN · INE435G01025 LEI · 335800E4DLZIC7MSG125 BSE.NS Manufacturing
Open in API
Filings indexed 1,595 across all filing types
Latest filing 2026-05-19 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS DHANUKA

About Dhanuka Agritech Ltd.

https://www.dhanuka.com/

Dhanuka Agritech Ltd. specializes in the manufacturing and marketing of a comprehensive range of crop protection solutions, including insecticides, herbicides, fungicides, and plant growth regulators. The company maintains strategic technical collaborations with several global chemical innovators to bring advanced formulations to the agricultural sector. Its product portfolio is supported by a robust research and development infrastructure and an extensive distribution network that facilitates the delivery of integrated pest management and soil health solutions. The organization focuses on enhancing agricultural productivity through the provision of high-quality inputs and technical advisory services. By leveraging a strong field force, it provides training and support to optimize crop yields and resource efficiency, ensuring the effective application of its diverse chemical and biological offerings.

Recent filings

Filing Released Lang Actions
General Updates
Interim / Quarterly Report Classification · 75% confidence The document is a formal SEBI Listing Regulation compliance filing announcing the Audited Financial Results for the quarter and full year ended March 31, 2026, accompanied by the Auditors’ Report and detailed financial schedules. It clearly includes substantive financial statements and audit opinions, not just highlights or a link to a report. Therefore it is a periodical financial report rather than a brief earnings summary or an AGM presentation. Under our taxonomy, it best fits the “Interim / Quarterly Report” category, which covers comprehensive financial statements for periods shorter than a full fiscal year (including quarterly results). FY 2026
2026-05-19 English
Change in Management
Regulatory Filings Classification · 90% confidence The document is a composite “Outcome of the Board Meeting” notice filed with the stock exchanges under SEBI Listing Regulations. It covers board approval of audited financial results, auditor’s report, ESOP/SAR plans, buyback proposal, dividend recommendation, AGM convening, management retirement, cost auditor reappointment, and subsidiary set-up approvals. It is not a standalone annual or interim report, nor purely an audit report, but rather a regulatory disclosure to exchanges. This falls into the general “Regulatory Filings” category (RNS).
2026-05-19 English
General Updates
Regulatory Filings Classification · 85% confidence The document is a formal SEBI Listing Regulation 30 announcement of the Board’s meeting outcomes: audited financial results (with auditor’s report), ESOP/SAR plans, share buyback proposal, dividend, AGM convening, management retirement, cost auditor re‐appointment, overseas subsidiary approvals, etc. It is not a standalone annual or quarterly report narrative but a composite regulatory filing under SEBI “Listing Obligations and Disclosure Requirements.” It does not fit neatly into a pure earnings release, dividend notice, or capital update and serves as a general compliance announcement. Hence it falls under the generic Regulatory Filings category (RNS).
2026-05-19 English
Board approved the 41st Annual General Meeting of the Company to be held on Monday, 3rd August, 2026 at 11:00 AM
Regulatory Filings Classification · 89% confidence The document is a Board Meeting Outcome notice filed under SEBI Listing Obligations (Regulation 33), announcing the approval of audited financial results, dividend recommendation, ESOP and SAR plans, buyback proposal, AGM date, retirement of senior management, and other corporate actions. It is a regulatory compliance filing with multiple disclosures—not the standalone annual report, not a proxy or AGM materials, not a transcript, nor a simple earnings highlight. It best fits the general “Regulatory Filings” category as a miscellaneous regulatory announcement under listing rules.
2026-05-19 English
Retirement
Regulatory Filings Classification · 87% confidence The document is the outcome of a Board Meeting disclosed to the stock exchanges under SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. It covers multiple regulatory compliance items – audited financial results, auditor’s report, ESOP/SAR plans, buyback proposal, dividend recommendation, AGM notice, management retirement, cost auditor appointment, and subsidiary approvals – rather than being a single financial report or a transcript. This type of broad compliance announcement under Listing Regulation 30 is classified as a general regulatory filing (RNS).
2026-05-19 English
Approval of Schemes of Dhanuka Employee Stock Option Plan 2026 and Dhanuka Stock Appreciation Rights Plan , 2026
Regulatory Filings Classification · 85% confidence The document is a SEBI Listing Regulations board meeting outcome announcement filed with the stock exchanges. It includes approval of audited financial results, auditor’s report, ESOP and SAR plans, buyback proposal, dividend, AGM details, retirement of personnel, auditors’ reappointment, and subsidiary approvals. It does not contain the full Annual Report (10-K) or a standalone Interim Report with comprehensive financial statements in the body, nor is it solely an audit report or earnings release. It is a mixed regulatory disclosure, fitting best into the generic “Regulatory Filings” category (RNS).
2026-05-19 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.